tiprankstipranks
Advertisement
Advertisement
Opus Genetics reports Q1 EPS (75c), consensus (14c)
PremiumThe FlyOpus Genetics reports Q1 EPS (75c), consensus (14c)
18d ago
IRD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IRD Upcoming Earnings Report: What to Expect?
24d ago
Opus Genetics announces FDA acceptance of OPGx-LCA5 into RDEP program
Premium
The Fly
Opus Genetics announces FDA acceptance of OPGx-LCA5 into RDEP program
26d ago
Opus Genetics Secures $155 Million Senior Note Financing
PremiumCompany AnnouncementsOpus Genetics Secures $155 Million Senior Note Financing
1M ago
Opus Genetics: Undervalued Gene Therapy Play on Upcoming Retinal Disease Data Catalysts
Premium
Ratings
Opus Genetics: Undervalued Gene Therapy Play on Upcoming Retinal Disease Data Catalysts
1M ago
Opus Genetics Shareholders Approve Governance and Capital Changes
Premium
Company Announcements
Opus Genetics Shareholders Approve Governance and Capital Changes
1M ago
Opus Genetics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyOpus Genetics initiated with an Overweight at Cantor Fitzgerald
2M ago
Opus Genetics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Opus Genetics initiated with an Overweight at Cantor Fitzgerald
2M ago
Oppenheimer bullish on Opus Genetics, initiates with an Outperform
Premium
The Fly
Oppenheimer bullish on Opus Genetics, initiates with an Outperform
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100